宫内节育器滞留妊娠:全国层面特征与结局评估
该研究利用美国全国住院患者样本,分析2016年1月至2020年12月18,067,310例住院分娩中宫内节育器滞留妊娠的发生率、临床特征及分娩结局,发现发生率为每100,000例住院分娩12.0例,并与多种高危妊娠特征和不良结局相关。
要点
- 宫内节育器滞留妊娠发生率为每100,000例住院分娩12.0例(1/8307)。
- 滞留节育器与胎膜早破、胎盘异常、胎儿畸形、死胎等风险升高相关。
- 滞留节育器组更常发生<22周妊娠丢失、22-25周围存活期分娩及胎盘滞留。
核心结论
- 全国性分析证实宫内节育器滞留妊娠不常见,但可能与高危妊娠特征和结局相关。
研究设计与样本
- 采用医疗成本与利用项目全国住院患者样本的系列横断面研究,纳入2016年1月至2020年12月18,067,310例住院分娩用于全国估计。
- 暴露为宫内节育器滞留状态,依据世界卫生组织国际疾病分类第十版代码O26.3识别。
- 为评估妊娠特征和分娩结局,构建逆概率处理加权队列以减轻滞留节育器的孕前混杂因素。
主要发现
- 宫内节育器滞留报告率为每8307例住院分娩1例(每100,000例12.0例)。
- 多变量分析中,西班牙裔、高产次、肥胖、饮酒和既往子宫瘢痕与宫内节育器滞留相关(均P<.05)。
- 当前妊娠特征中,滞留节育器组与对照组比较:胎膜早破9.2% vs 2.7%(调整比值比3.15,95%置信区间2.41-4.12);胎位不正10.9% vs 7.2%(调整比值比1.47,95%置信区间1.15-1.88);胎儿畸形2.2% vs 1.1%(调整比值比1.71,95%置信区间1.03-2.85);宫内胎儿死亡2.6% vs 0.8%(调整比值比2.21,95%置信区间1.37-3.57);胎盘畸形1.8% vs 0.8%(调整比值比2.12,95%置信区间1.20-3.76);胎盘早剥4.7% vs 1.1%(调整比值比3.24,95%置信区间2.25-4.66);胎盘植入谱系0.7% vs 0.1%(调整比值比4.82,95%置信区间1.99-11.65)。
- 分娩特征中,滞留节育器组与对照组比较:<22周妊娠不可存活丢失3.4% vs 0.3%(调整比值比5.49,95%置信区间3.30-9.15);22至25周围存活期分娩3.1% vs 0.5%(调整比值比2.81,95%置信区间1.63-4.86)。
- 滞留节育器组更可能诊断为分娩时胎盘滞留(2.5% vs 0.4%;调整比值比4.45,95%置信区间2.70-7.36)和接受人工胎盘剥离(3.2% vs 0.6%;调整比值比4.81,95%置信区间3.11-7.44)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although intrauterine devices provide effective contraceptive protection, unintentional pregnancy can occur. Previous studies have shown that a retained intrauterine device during pregnancy is associated with adverse pregnancy outcomes but there is a paucity of nationwide data and analysis. OBJECTIVE: This study aimed to describe characteristics and outcomes of pregnancies with a retained intrauterine device. STUDY DESIGN: This serial cross-sectional study used data from the Healthcare Cost and Utilization Project's National Inpatient Sample. The study population comprised 18,067,310 hospital deliveries for national estimates from January 2016 to December 2020. The exposure was retained intrauterine device status, identified by the World Health Organization's International Classification of Diseases, Tenth Revision, code O26.3. The co-primary outcome measures were incidence rate, clinical and pregnancy characteristics, and delivery outcome of patients with a retained intrauterine device. To assess the pregnancy characteristics and delivery outcomes, an inverse probability of treatment weighting cohort was created to mitigate the prepregnant confounders for a retain intrauterine device. RESULTS: A retained intrauterine device was reported in 1 in 8307 hospital deliveries (12.0 per 100,000). In a multivariable analysis, Hispanic individuals, grand multiparity, obesity, alcohol use, and a previous uterine scar were patient characteristics associated with a retained intrauterine device (all P<.05). Current pregnancy characteristics associated with a retained intrauterine device included preterm premature rupture of membrane (9.2% vs 2.7%; adjusted odds ratio, 3.15; 95% confidence interval, 2.41-4.12), fetal malpresentation (10.9% vs 7.2%; adjusted odds ratio, 1.47; 95% confidence interval, 1.15-1.88), fetal anomaly (2.2% vs 1.1%; adjusted odds ratio, 1.71; 95% confidence interval, 1.03-2.85), intrauterine fetal demise (2.6% vs 0.8%; adjusted odds ratio, 2.21; 95% confidence interval, 1.37-3.57), placenta malformation (1.8% vs 0.8%; adjusted odds ratio, 2.12; 95% confidence interval, 1.20-3.76), placenta abruption (4.7% vs 1.1%; adjusted odds ratio, 3.24; 95% confidence interval, 2.25-4.66), and placenta accreta spectrum (0.7% vs 0.1%; adjusted odds ratio, 4.82; 95% confidence interval, 1.99-11.65). Delivery characteristics associated with a retained intrauterine device included previable loss at <22 weeks' gestation (3.4% vs 0.3%; adjusted odds ratio, 5.49; 95% confidence interval, 3.30-9.15) and periviable delivery at 22 to 25 weeks' gestation (3.1% vs 0.5%; adjusted odds ratio, 2.81; 95% confidence interval, 1.63-4.86). Patients in the retained intrauterine device group were more likely to have a diagnosis of retained placenta at delivery (2.5% vs 0.4%; adjusted odds ratio, 4.45; 95% confidence interval, 2.70-7.36) and to undergo manual placental removal (3.2% vs 0.6%; adjusted odds ratio, 4.81; 95% confidence interval, 3.11-7.44). CONCLUSION: This nationwide analysis confirmed that pregnancy with a retained intrauterine device is uncommon, but these pregnancies may be associated with high-risk pregnancy characteristics and outcomes.
引用
- Panchal VR, Rau AR, Mandelbaum RS, et al. Pregnancy with retained intrauterine device: national-level assessment of characteristics and outcomes. Am J Obstet Gynecol MFM. 2023. PMID: 37330009. doi:10.1016/j.ajogmf.2023.101056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。